‹ All questions

Ventas vs ARE: which stock is doing better?

Ventas and ARE are business rivals. Where they compete: life-science / medical research real estate (overlaps OM&R life-science segment). Here is how the two stocks, and the businesses behind them, compare over the past year.

Updated Oct 9, 2026

30
VTR P3

VTR ahead

On Stox’s P3 score, which combines market beat, staying power and business growth, Ventas rates 30 and ARE 7. Over the past year Ventas is +21% and ARE −39%, against +16% for the S&P 500. Ventas has grown revenue faster, +21% against −5%. Ventas swings less, about 2.0% on a typical day against 3.9%. By type, Ventas is a Churning Winner and ARE a Bottom Fished.

VTR P3 30ARE P3 7Both in REITs / real estate

The past year

VTR against ARE, each set to $100 a year ago. Select a measure in the table below to chart it for both.

VTR against ARE, past year
$100 a year ago. VTR +21%, ARE −39%.
50100NovDecJanFebMarAprMayJunJulAugSepOct
VTRARE

VTR and ARE side by side

Ahead marks the stronger reading on each line; for the typical day and the deepest fall it marks the steadier stock. Select a row with a chart to see both over the year.

MeasureVTRAREAhead
Past 3 months
Share price change
−11%−5%ARE
Past month
Share price change
−9%−8%ARE
Revenue growth
Past four quarters against the year before
+21%−5%VTR
Operating margin
Operating profit as a share of revenue, past four quarters
13%-43%VTR
Deepest fall
From a high, past year
−20%−48%VTR, held up
Market value
What the market values the company at
$39.9B$7.9B
Type
Its Stox Atlas type
Churning WinnerBottom Fished
Group
Stocks it moves with
REITs / real estateREITs / real estateSame group

How to read this page

How it’s measured. Scores from Stox rank each stock against about 1,200 large US stocks and funds, where 100 is best; P3 combines market beat, staying power and business growth. Returns are share-price changes. The typical day is the average true range over 14 days as a share of the price, averaged over the past year.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and curated rivals from Stox.

A higher score describes a stronger past year, not what comes next.

Rivals are chosen by the markets the two businesses compete in, not by sector labels.

For financial statements, valuation and news, see VTR and ARE on Stox.

This page is information, not investment advice. About our data and methods ›

More head-to-heads

See all questions ›